Article
Selecta's (SELB) Gene Therapy Gets Rare Pediatric Disease Tag
Rating:
0.0
Views:
100
Likes:
1
Library:
1
The FDA bestows a Rare Pediatric Disease status on Selecta's (SELB) gene therapy candidate MMA-101, which is being developed for the treatment of isolated methylmalonic acidemia.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value